Moneycontrol PRO
Loans
HomeNewsGilletteindia

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Trade Spotlight | What should you do with Adani Total Gas, Granules India, Bank of Baroda on Tuesday?

    Granules India witnessed positive divergence between the prices and RSI indicator. The divergence is followed by breakout in RSI as well which indicates a strong momentum in the stock prices.

  • Trade Spotlight | What should you do with Granules India, Welspun Corp, JK Lakshmi Cement on Monday?

    Trade Spotlight | What should you do with Granules India, Welspun Corp, JK Lakshmi Cement on Monday?

    Currently JK Lakshmi Cement is well placed above 20, 50 and 100 day SMA. The daily weekly strength indicator RSI is in bullish terrain which supports rising momentum. The daily "band Bollinger" buy signal indicates increased momentum.

  • Hot Stocks | Here is why you should bet on Granules India, NMDC for short term

    Hot Stocks | Here is why you should bet on Granules India, NMDC for short term

    Traders can look to buy Granules India on a decline at around Rs 305 for a near-term target of Rs 322. The stoploss can be placed at Rs 294

  • Hot Stocks | Buy RPG Life Science, BEML, but sell Granules India. Here's why

    Hot Stocks | Buy RPG Life Science, BEML, but sell Granules India. Here's why

    Previous swing low support is placed at 17,254 which can act as immediate support for the Nifty.

  • Hot Stocks | Granules, Welspun India, Wipro can give up to 18% return in short term

    Hot Stocks | Granules, Welspun India, Wipro can give up to 18% return in short term

    Key support level to watch out for on Nifty, from a short-term perspective, is 15,600. If the index breaches below this level, we can expect further downside towards 15,450 and 15,100-15,145, said Karan Pai of GEPL Capital.

  • Budget 2021 | Focus on healthcare but mixed bag for pharma, 9 stocks you can pick from sector

    Budget 2021 | Focus on healthcare but mixed bag for pharma, 9 stocks you can pick from sector

    The sector was in focus in Union Budget 2021. Finance Minister Nirmala Sitharaman in her Budget speech announced an outlay of Rs 2,23,846 crore for health and well being.

  • Good time to build a portfolio, brokerages pick 20 stocks for 13-49% return

    Good time to build a portfolio, brokerages pick 20 stocks for 13-49% return

    With midcaps and smallcaps expected to outperform largecaps, especially after September quarter earnings, this is the right time to build a portfolio, analysts have said.

  • Analysts upgrade 31 stocks to 'buy' after Q2 earnings, can return 10-50%

    Analysts upgrade 31 stocks to 'buy' after Q2 earnings, can return 10-50%

    The benchmark indices and broader markets have rallied more than 55 percent from the lows of March 23, though they have been some correction in the last few sessions.

  • Analysts upgrade earning estimates on these 12 stocks post Q2 show; do you own any?

    Analysts upgrade earning estimates on these 12 stocks post Q2 show; do you own any?

    The Q2FY21, so far, witnessed robust numbers from IT, Pharma, Auto components, select banks, and cement sector companies.

  • Brokerage firm Emkay Global is bullish on these 10 stocks, do you own any?

    Brokerage firm Emkay Global is bullish on these 10 stocks, do you own any?

    As the uncertainty persists, a stock-specific approach is what one needs to follow in this market.

  • Hot Stocks | Apollo Hospitals, Wipro, Granules India three buy calls for short-term

    Hot Stocks | Apollo Hospitals, Wipro, Granules India three buy calls for short-term

    The index is trading near 261.8 percent Fibonacci projected level, based on the previous week's trading range, suggesting that bears might take a breather.

  • Pockets of opportunity: Analysts pick 12 midcap stocks with one-year horizon

    Pockets of opportunity: Analysts pick 12 midcap stocks with one-year horizon

    The road ahead for the market is bumpy and a lot will depend on the course of coronavirus pandemic. Moreover, global cues and measures of governments and central banks will remain important factors for the market.

  • Worst may be behind: Experts suggest these 10 stocks for your portfolio

    Worst may be behind: Experts suggest these 10 stocks for your portfolio

    The market is expected to break out of its 3-month high soon and Nifty may hit 10,300 this week itself, feels an expert

  • Hot Stocks | Granules India, Dr Lal Path Lab, Navin Flourine are short-term buys

    Hot Stocks | Granules India, Dr Lal Path Lab, Navin Flourine are short-term buys

    Positional Support for Nifty is seen at 8,900, and unless that is breached, the short-term trend of the market would be considered bullish only.

  • Q3 earnings mixed so far; brokerages maintain 'buy' on 10 stocks with 9-23% upside

    Q3 earnings mixed so far; brokerages maintain 'buy' on 10 stocks with 9-23% upside

    Last week, FIIs bought equities worth Rs 1,790.6 crore, while Domestic Institutional Investors sold equities worth of Rs 2,620.48 crore

  • Hot Stocks: Technical indicators show signs of bullishness, strong support at 11,700-11,800

    Hot Stocks: Technical indicators show signs of bullishness, strong support at 11,700-11,800

    The primary trend of Nifty is bullish as the index is trading above its 50, 100 and 200 DMAs. Higher tops and higher bottoms are well intact. So, technical indicators are suggesting that the positional trend of the market is bullish.

  • Time to buy mid & smallcaps? Brokerages initiate buy calls on 10 stocks in November

    Time to buy mid & smallcaps? Brokerages initiate buy calls on 10 stocks in November

    DII and FII buying at various bottoms have arrested the downfall and we see buying interest from various market participants, said Vijay Kuppa of Orowealth.

  • These 9 mid & smallcap stocks look attractive in a fragile market; do you own any?

    These 9 mid & smallcap stocks look attractive in a fragile market; do you own any?

    Market experts advise a prudent, stock-specific approach in such an uncertain market

  • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar, Prakash Gaba for short term

    Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar, Prakash Gaba for short term

    Mitessh Thakkar of mitesshthakkar.com suggests buying Granules India with a stop loss of Rs 99 and target of Rs 106, NBCC with a stop loss of Rs 55 and target of Rs 64 and Torrent Pharma with a stop loss of Rs 1677 and target of Rs 1800.

  • Top 10 moneymaking ideas which could give 4-11% return in 1 month based on technicals

    Top 10 moneymaking ideas which could give 4-11% return in 1 month based on technicals

    On the lower side, 11484 followed by 11436 would now be seen as immediate and crucial supports. At this juncture, a strategy would be to focus on individual pockets that are providing better trading opportunities, says Sameet Chavan of Angel Broking.

  • Top buy & sell ideas by Ashwani Gujral, Prakash Gaba, Mitessh Thakkar for short term

    Top buy & sell ideas by Ashwani Gujral, Prakash Gaba, Mitessh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com suggests buying Balrampur Chini with a stop loss of Rs 76 and target of Rs 81, Bosch with a stop loss of Rs 20,900 and target of Rs 22,000 and Cadila Heathcare with a stop loss of Rs 412 and target of Rs 445.

  • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Prakash Gaba for short term

    Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Prakash Gaba for short term

    Ashwani Gujral of ashwanigujral.com suggests buying Dr Reddy's Labs with a stop loss of Rs 2470, target of Rs 2550, NIIT Tech with a stop loss of Rs 1395, target of Rs 1430 and Bank of Baroda with a stop loss of Rs 148, target of Rs 160.

  • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com suggests buying IDFC with a stop loss of Rs 47.5 and target of Rs 56, M&M above Rs 945 with stop loss of Rs 934 and target of Rs 980 and Muthoot Finance with a stop loss of Rs 414 and target of Rs 450.

  • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

    Mitessh Thakkar of mitesshthakkar.com recommends buying KPIT Technologies with a stop loss of Rs 301 and target of Rs 320 and Sun Pharmaceutical Industries with a stop loss of Rs 564 and target of Rs 595 and advises selling Colgate Palmolive with a stop loss of Rs 1136 and target of Rs 1090.

  • Buy Granules India: Motilal Oswal

    Buy Granules India: Motilal Oswal

    Granules India 1QFY19 sales grew 17 percent YoY to Rs 450 crore, led by finished dosages and APIs.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347